Research Progress of Takeda G Protein-Coupled Receptor 5 in Metabolic Syndrome

24Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

Bile acids are acknowledged as signaling molecules involved in metabolic syndrome. The Takeda G protein-coupled receptor 5 (TGR5) functions as a significant bile acid receptor. The accumulated evidence suggests that TGR5 involves lipid homeostasis, glucose metabolism, and inflammation regulation. In line with this, recent preclinical studies also demonstrate that TGR5 plays a significant role in the generation and progression of metabolic syndrome, encompassing type 2 diabetes mellitus, obesity, atherosclerosis, and non-alcoholic fatty liver disease (NAFLD). In this review, we discuss the role of TGR5 in metabolic syndrome, illustrating the underlying mechanisms and therapeutic targets.

Cite

CITATION STYLE

APA

Gou, X., Qin, L., Wu, D., Xie, J., Lu, Y., Zhang, Q., & He, Y. (2023, August 1). Research Progress of Takeda G Protein-Coupled Receptor 5 in Metabolic Syndrome. Molecules. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/molecules28155870

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free